Latest updates from your local medical community
NHSE/I has published a letter about the outcome of general practice site designation process to provide commissioners and practices with more information to help with planning. This follows on from a letter that NHSE/I sent to NHS Trusts last week, outlining the wider COVID-19 vaccination deployment strategy and operational readiness for mass immunisation sites.
The RCGP and BMA have issued new guidance on workload prioritisation during the pandemic.
The guidance on workload prioritisation details six 'response levels' for practices, depending on COVID-19 prevalence in their area. These range from 0 when the pandemic is effectively over to level 5 where prevalence is very high and practices are in an 'emergency response' state.
The BMA General Practitioners Committee in England has now agreed with NHS England and NHS Improvement the general practice COVID-19 vaccination service which will be commissioned in line with agreed national terms and conditions as an enhanced service (ES).
During these unprecedented times, we know everyone is working hard to deliver care to their patients and ensure their workforces are protected too. In order to support our members we have created a dedicated COVID19 link and resources to keep you up-to-date on the fast moving and ever changing COVID-19 guidelines and advice. We're updating the page on a daily basis as soon as we source new information, to ensure our members have easy access to the information needed. All the latest guidance and links can be found here:
We are also updating our non-COVID19 guidance page on a regular basis too. A link to the main page can be found here:
The following link is an extremely useful set of explanatory notes on the effect of the new Act. The purpose of the Coronavirus Bill is to enable the Government to respond to an emergency situation and manage the effects of a Covid-19 pandemic.
The LMC office is open Monday to Thursday 9am to 5pm. We endeavour to respond to all enquiries within 5 working days. In the first instance, please use our Contact Us page.
You can also visit our CV19 page for the latest CV19 guidance.